Biochemical and biophysical properties of the core-binding factor alpha 2 (AML1) DNA-binding domain

被引:53
|
作者
Crute, BE
Lewis, AF
Wu, ZN
Bushweller, JH
Speck, NA
机构
[1] DARTMOUTH COLL,SCH MED,DEPT CHEM,HANOVER,NH 03755
[2] DARTMOUTH COLL,SCH MED,DEPT BIOCHEM,HANOVER,NH 03755
[3] DARTMOUTH COLL,SCH MED,DEPT PHARMACOL & TOXICOL,HANOVER,NH 03755
关键词
D O I
10.1074/jbc.271.42.26251
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Runt domain is the DNA-binding domain defining a small family of transcription factors that are involved in important developmental processes. Developmental pathways controlled by Runt domain proteins include sex determination, neurogenesis, segmentation, and eye development in Drosophila and hematopoiesis in mammals. In addition to binding DNA, the Runt domain also mediates heterodimerization with another subunit called the core-binding factor beta (CBF beta) subunit. In this study we overexpress the Runt domain from the mouse CBF alpha 2 (AML1) protein in Escherichia coli, and purify it from the insoluble fraction. We determine the equilibrium constants for Runt domain binding to two different DNA sequences by surface plasmon resonance technology. Circular dichroism spectroscopy demonstrates that the Runt domain is a folded beta-domain with essentially no alpha-helical content. The single tryptophan residue in the CBF alpha 2 Runt domain at amino acid 79 is shown by tryptophan fluorescence spectroscopy to reside in a polar environment. Finally, we demonstrate that ATP can be UV cross-linked to the Runt domain and that ATP binding is sensitive to an amino acid substitution in the putative Kinase-1a motif (P-loop).
引用
收藏
页码:26251 / 26260
页数:10
相关论文
共 50 条
  • [41] Dimerization and DNA-binding properties of the transcription factor ΔFosB
    Jorissen, Helena J. M. M.
    Ulery, Paula G.
    Henry, Lisa
    Gourneni, Sreekrishna
    Nestler, Eric J.
    Rudenko, Gabby
    BIOCHEMISTRY, 2007, 46 (28) : 8360 - 8372
  • [42] DNA-binding domain of AML1, expressed in t(8;21) and t(3;21) myeloid leukemias, inhibits PEBP2/CBF DNA-binding but is not sufficient to transform 32D cl3 myeloid cells
    BritosBray, M
    Sacchi, N
    Friedman, AD
    LEUKEMIA, 1996, 10 (06) : 984 - 990
  • [43] Biochemical and biophysical characterization of the nucleic acid binding properties of the RNA/DNA binding protein EWS
    Selig, Emily E.
    Bhura, Roohi
    White, Matthew R.
    Akula, Shivani
    Hoffman, Renee D.
    Tovar, Carmel N.
    Xu, Xiaoping
    Booth, Rachell E.
    Libich, David S.
    BIOPOLYMERS, 2023, 114 (05)
  • [44] Crystallographic characterization of the DNA-Binding domain of interferon regulatory factor-2 complexed with DNA
    Kusumoto, M
    Fujii, Y
    Tsukuda, Y
    Ohira, T
    Kyougoku, Y
    Taniguchi, T
    Hakoshima, T
    JOURNAL OF STRUCTURAL BIOLOGY, 1998, 121 (03) : 363 - 366
  • [45] SNAPc:: a core promoter factor with a built-in DNA-binding damper that is deactivated by the Oct-1 POU domain
    Mittal, V
    Ma, BC
    Hernandez, N
    GENES & DEVELOPMENT, 1999, 13 (14) : 1807 - 1821
  • [46] DNA-Binding Property of the Novel DNA-Binding Domain STPR in FMBP-1 of the Silkworm Bombyx mori
    Takiya, Shigeharu
    Saito, Shin
    Yokoyama, Takuya
    Matsumoto, Daisuke
    Aizawa, Tomoyasu
    Kamiya, Masakatsu
    Demura, Makoto
    Kawano, Keiichi
    JOURNAL OF BIOCHEMISTRY, 2009, 146 (01): : 103 - 111
  • [47] Chloride binding by the AML1/Runx1 transcription factor studied by NMR
    Wolf-Watz, M
    Bäckström, S
    Grundström, T
    Sauer, U
    Härd, T
    FEBS LETTERS, 2001, 488 (1-2): : 81 - 84
  • [48] Multidrug resistance (MDR) in acute myeloid leukemia (AML) with core-binding factor (CBF) abnormalities.
    Baer, MR
    O'Loughlin, KL
    Minderman, H
    Sait, SN
    Flood, JJ
    Sorci, JJ
    Stewart, CC
    BLOOD, 1999, 94 (10) : 64A - 64A
  • [49] Expression and purification of the DNA-binding domain of the human transcription factor E2F1
    Zeng, WY
    Zhang, XC
    Tu, XM
    Guang, SH
    Xiao, YZ
    Shi, YY
    PROTEIN EXPRESSION AND PURIFICATION, 2001, 21 (01) : 99 - 104
  • [50] Oncogenic point mutations in the Myb DNA-binding domain alter the DNA-binding properties of Myb at a physiological target gene
    Ivanova, Olga
    Braas, Daniel
    Klempnauer, Karl-Heinz
    NUCLEIC ACIDS RESEARCH, 2007, 35 (21) : 7237 - 7247